Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Spleen trauma during pregnancy (a case report)].
Annales francaises d'anesthesie et de reanimation·2003
[Respiratory failure caused by megaesophagus and tracheomalacia].
Annales francaises d'anesthesie et de reanimation·2000
Improvement of internal jugular vein cannulation using an ultrasound-guided technique.
Intensive care medicine·1997
[Headaches after spinal anesthesia: prospective multicenter study of a young adult population].
Annales francaises d'anesthesie et de reanimation·1997
Intrapericardial fibrinolysis: a useful treatment in the management of purulent pericarditis.
Intensive care medicine·1997
[Study of cellular immunity by the nuclear refringence test during general anesthesia].
Annales de l'anesthesiologie francaise·1981
[Method for prolonged hemodynamic and respiratory monitoring. I. Technical study involving 45 patients].
Annales de l'anesthesiologie francaise·1981
[Evaluation of a method for the measurement of static total compliance (Siemens Elema LMC 940 calculator)].
Annales de l'anesthesiologie francaise·1981
[Variations in blood prolactin in man during enflurane or Alfatésine anesthesias].
Annales de l'anesthesiologie francaise·1981
[Is the use of lidocaine in spray form permissible during intubation?].
Annales de l'anesthesiologie francaise·1981
Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myeloma.
medRxiv : the preprint server for health sciences·2026
Mitochondrial rewiring supports survival of triple negative breast cancer cells after ionizing radiation.
bioRxiv : the preprint server for biology·2026
A mammary-specific microfluidic device for studying post-radiotherapy vascular-immune cell interactions.
bioRxiv : the preprint server for biology·2026
Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer.
bioRxiv : the preprint server for biology·2026
Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis.
medRxiv : the preprint server for health sciences·2026